Valuation: InfuSystem Holdings, Inc.

Market Cap 184M 160M 149M 137M 259M 17.61B 263M 1.76B 690M 8.77B 693M 678M 29.4B P/E 2026 *
21.5x
P/E 2027 * 16.8x
Enterprise Value 184M 160M 149M 137M 259M 17.61B 263M 1.76B 690M 8.77B 693M 678M 29.4B EV / Sales 2026 *
1.27x
EV / Sales 2027 * 1.18x
Free-Float
92.85%
Yield 2026 *
-
Yield 2027 * -
1 day-0.54%
1 week+0.22%
1 month-8.78%
3 months-11.86%
6 months+10.65%
Current year+1.90%
1 week 8.88
Extreme 8.88
10
1 month 8.69
Extreme 8.6901
10.24
Current year 7.29
Extreme 7.29
11
1 year 5.69
Extreme 5.69
11.04
3 years 4.61
Extreme 4.61
11.44
5 years 4.61
Extreme 4.61
20.59
10 years 1.2
Extreme 1.2
23.26
Manager TitleAgeSince
Chief Executive Officer 49 2025-05-18
Director of Finance/CFO 55 2020-03-11
Chief Tech/Sci/R&D Officer 47 -
Director TitleAgeSince
Chairman 60 2018-12-18
Director/Board Member 64 2019-05-14
Director/Board Member 49 2021-03-17
Date Insider Type Main position Quantity % Market Cap.
5/18/26 Fiscal year

Chief Financial Officer

21,230 0.1050%
10/9/25 Other

Head of Human Resources

28,669 0.1348%
9/23/25 Other

Chief Executive Officer

69,675 0.3277%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+0.22%+60.35%-9.59% 184M
+0.09%+2.56%-16.96%-4.37% 183B
-0.37%+2.62%-4.42%-2.61% 109B
-0.29%+0.47%+7.97%+64.64% 60.57B
+3.50%+0.47%+41.00%+46.44% 51.8B
+0.10%+5.92%-6.10%-40.54% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+5.26%-31.60% 31.49B
+0.40%+3.89%+42.51%-8.26% 24B
-1.22%+6.69%+0.67%+1.96% 22.26B
Average +1.40%+4.39%+14.48%+1.79% 56.14B
Weighted average by Cap. +0.92%+3.49%-0.09%+4.23%

Financials

2026 *2027 *
Net sales 145M 126M 117M 108M 203M 13.82B 206M 1.38B 542M 6.88B 544M 532M 23.07B 156M 135M 126M 116M 218M 14.86B 222M 1.49B 583M 7.4B 585M 572M 24.81B
Net income 8.85M 7.69M 7.16M 6.57M 12.41M 844M 12.6M 84.36M 33.11M 420M 33.22M 32.49M 1.41B 11.45M 9.95M 9.26M 8.5M 16.06M 1.09B 16.31M 109M 42.85M 544M 42.99M 42.05M 1.82B
Net Debt - -
Logo InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Employees
467
Date Price Change Volume
26-07-31 US$9.140 -0.54% 172,806
26-07-30 US$9.190 -5.84% 150,914
26-07-29 US$9.760 -1.61% 173,243
26-07-28 US$9.920 +5.98% 114,170
26-07-27 US$9.360 +2.63% 128,952
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.140USD
Average target price
14.88USD
Spread / Average Target
+62.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INFU Stock